{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:43Z","timestamp":1786119583507,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/cnd.0b013e3181df2b3e","type":"journal-article","created":{"date-parts":[[2011,2,12]],"date-time":"2011-02-12T10:36:19Z","timestamp":1297506979000},"page":"163-164","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Rituximab in the Treatment of MuSK Antibody-Positive Myasthenia Gravis"],"prefix":"10.1097","volume":"12","author":[{"given":"Beth","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn J","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20240808","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/CND.0b013e31819a8403","article-title":"Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review.","volume":"10","author":"Nelson","year":"2009","journal-title":"J Clin Neuromuscular Dis"},{"key":"R2-10-20240808","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1196\/annals.1405.005","article-title":"Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.","volume":"1132","author":"Wolfe","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R3-10-20240808","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mus.20479","article-title":"Successful treatment of MuSk antibody-positive myasthenia gravis with rituximab.","volume":"33","author":"Hain","year":"2006","journal-title":"Muscle Nerve"},{"key":"R4-10-20240808","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2008.04.039","article-title":"Sustained response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients.","volume":"2001-","author":"Illa","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R5-10-20240808","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00415-006-0442-2","article-title":"Rituximab in refractory MuSK antibody myasthenia gravis.","volume":"254","author":"Thakre","year":"2007","journal-title":"J Neurol"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00131402-201103000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:54:36Z","timestamp":1786042476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00131402-201103000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0b013e3181df2b3e","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}